Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants — Stella

Home/Bronchopulmonary Dysplasia/Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants

View on ClinicalTrials.gov

Recruiting

Back to Bronchopulmonary Dysplasia trials

Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Taiwan

National Chen-Kung University Hospital, Tainan

Key details

Phase

Early testing

Sponsor

Meridigen Biotech Co., Ltd.

Enrollment target

~9 participants

Started

October 2018

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

3 Days – 51 Days

Last updated December 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.